CollPlant Biotechnologies (CLGN) Assets (2017 - 2025)
CollPlant Biotechnologies' (CLGN) quarterly Assets came in at $10.8 million in Q4 2025, down 42.36% YoY from $18.7 million in Q4 2024, and down 23.45% on a QoQ basis from $14.1 million in Q3 2025.
CollPlant Biotechnologies (CLGN) Assets (2017 - 2025) Analysis & Trends
CollPlant Biotechnologies (CLGN) has 9 years of Assets data on file, last reported at $10.8 million in Q4 2025.
- Quarterly Assets fell 42.36% year-over-year to $10.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $10.8 million (down 42.36% YoY) and the FY2025 annual result came in at $10.8 million, down 42.36% from the prior year.
- Assets fell to $10.8 million in Q4 2025, from $14.1 million in the prior quarter.
- In the past five years, Assets ranged from a high of $55.0 million in Q2 2021 to a low of $22442.0 in Q3 2024.
- A 5-year average of $27.9 million and a median of $34.1 million in 2023 frame the typical range for Assets.
- Annual changes were most pronounced in 2022 — Assets soared 85931.36% — and 2024, when it plunged 99.92%.
- Tracing CLGN's Assets over 5 years: stood at $51.2 million in 2021, then slipped by 26.27% to $37.8 million in 2022, then fell by 9.64% to $34.1 million in 2023, then plunged by 45.17% to $18.7 million in 2024, then slumped by 42.36% to $10.8 million in 2025.
- The last three Assets figures came in at $10.8 million (Q4 2025), $14.1 million (Q3 2025), and $17.4 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 5.56 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 2.10 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 19.82 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 25.60 Bn |
| 10 | CollPlant Biotechnologies | 4.13 Mn | 4.13 Mn | -243,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 10.79 Mn |
| Sep 30, 2025 | 14.09 Mn |
| Jun 30, 2025 | 17.44 Mn |
| Dec 31, 2024 | 18.71 Mn |
| Sep 30, 2024 | 22,442.00 |
| Jun 30, 2024 | 26.57 Mn |
| Mar 31, 2024 | 30,293.00 |
| Dec 31, 2023 | 34.13 Mn |
| Sep 30, 2023 | 37,558.00 |
| Jun 30, 2023 | 41.57 Mn |
| Mar 31, 2023 | 35.76 Mn |
| Dec 31, 2022 | 37.77 Mn |
| Sep 30, 2022 | 40.56 Mn |
| Jun 30, 2022 | 44.41 Mn |
| Mar 31, 2022 | 48.72 Mn |
| Dec 31, 2021 | 51.22 Mn |
| Sep 30, 2021 | 53.63 Mn |
| Jun 30, 2021 | 55.02 Mn |
| Mar 31, 2021 | 56,634.00 |
| Dec 31, 2020 | 10.84 Mn |